Global health governance in the 21st century has been characterized by the rise of new actors, new problems, and new processes. While a lot of attention has been given to the negotiation of rules and norms to address health challenges at the global level, we still do not know much about how international health norms and rules are set at the regional level.This roundtable series will focuses on how global health rules, norms, and standards are established and how they should be developed in the future.

This roundtable series is sponsored by the International Institutions and Global Governance Program and made possible by the generous support of the Robina Foundation.

This roundtable series focuses on the emerging state and non-state actors in global health and their role in a changing governance structure.

This roundtable series is sponsored by the International Institutions and Global Governance Program and made possible by the generous support of the Robina Foundation.

Every year nearly ten million children and millions of adults die and countless more suffer from preventable causes because they do not have access to the health care they need.This roundtable series addresses the need for and examines the means to achieve universal health coverage.

This roundtable series is made possible by the generous support of the Rockefeller Foundation.

• Meeting Note: World Health Organization Reform (PDF)

This workshop was sponsored by the International Institutions and Global Governance program and made possible by the generous support of the Robina Foundation.

• Rapporteur Report: Can Safety Be Ensured in a Time of Increased Globalization? (PDF)

The goal of the series is to examine the changing landscape of global health governance in the context of emerging powers, empowered non-governmental actors, and shifting health priorities. A number of questions will be discussed, including: What effect will the growing burden of noncommunicable diseases have on the economic growth of India and China? Can the WHO maintain a central role in global health governance, with competition from other actors (e.g., World Bank, WTO, MNCs, Gates Foundation) and the proliferation of new initiatives not housed by WHO (e.g., Global Fund)? How will the emerging powers (e.g., China, India, Brazil) and the rising nonstate actors affect the international community's ability to set priorities and define the upper limits of acceptable action? How does the entrance of health into the realm of "high politics" affect our way of handling transnational health threats?

Four roundtables will take place throughout the winter and spring in New York and Washington, DC.

This roundtable series is sponsored by the International Institutions and Global Governance program and made possible by the generous support of the Robina Foundation.